Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




World’s First AI-Powered Diagnostic Test Accurately Identifies Respiratory Viruses in Five Minutes

By LabMedica International staff writers
Posted on 09 Feb 2023

Current testing methods for respiratory viruses – such as a lateral flow test for COVID-19 – are limited to testing for just one infection or are either lab-based and time-consuming or fast and less accurate. More...

Now, a world-first diagnostic test powered by artificial intelligence (AI) that can identify known respiratory viruses within five minutes from just one nasal or throat swab could replace the current testing methods.

The ground-breaking virus detection and identification methodology has been described in a paper published in ACS Nano by researchers at University of Oxford (Oxford, UK). The paper demonstrates how machine learning can significantly improve the efficiency, accuracy and time required to identify different types of viruses, as well as differentiate between the strains. The technology combines molecular labeling, computer vision and machine learning to create a universal diagnostic imaging platform that looks directly at a patient sample and identifies which pathogen is present within seconds – similar to facial recognition software, but for germs.

In preliminary studies, the researchers have shown that the test can identify the COVID-19 virus in patient samples and further research determined that the test could be used for diagnosing multiple respiratory infections. In a study to validate the new method that uses AI software to identify viruses, the researchers began by labeling viruses with single-stranded DNA in more than 200 clinical samples. The images of labeled samples were captured using a commercial fluorescence microscope and processed by custom machine-learning software that is trained to recognize specific viruses by analyzing their fluorescence labels, which show up differently for each virus due to their varying surface size, shape and chemistry. The study showed that the technology is capable of rapidly identifying different types and strains of respiratory viruses, including flu and COVID-19, within five minutes and with an accuracy of >97%.

“Our simplified method of diagnostic testing is quicker and more cost-effective, accurate and future proof than any other tests currently available,” said Dr. Nicole Robb from the University of Warwick and Visiting Lecturer at Oxford’s Department of Physics. “If we want to detect a new virus, all we need to do is retrain the software to recognize it, rather than develop a whole new test. Our findings demonstrate the potential for this method to revolutionize viral diagnostics and our ability to control the spread of respiratory illnesses.”

Related Links:
University of Oxford


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Urinalysis Solution
UN-9000
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.